Kelly Virgil
Psychiatric/Mental Health · High Point, NCNPI 1992743991
Payments from drug & device makers
Across 157 payments — averaging $24.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$661
- Alkermes, Inc.$642
- Otsuka America Pharmaceutical, Inc.$601
- Indivior Inc.$320
- Teva Pharmaceuticals USA, Inc.$262
- E.r. Squibb & Sons, L.L.C.$219
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,80197%
- Education$1233%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 26 | $661 |
| Alkermes, Inc. | 17 | $642 |
| Otsuka America Pharmaceutical, Inc. | 21 | $601 |
| Indivior Inc. | 12 | $320 |
| Teva Pharmaceuticals USA, Inc. | 11 | $262 |
| E.r. Squibb & Sons, L.L.C. | 11 | $219 |
| Lundbeck LLC | 11 | $206 |
| Neurocrine Biosciences, Inc. | 8 | $198 |
| Braeburn Inc. | 7 | $164 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $144 |
| Corium, LLC | 5 | $134 |
| Axsome Therapeutics, Inc. | 5 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Ironshore Pharmaceuticals Inc. | 3 | $47 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
| Tris Pharma Inc | 2 | $28 |
| Johnson & Johnson | 1 | $22 |
| Almatica Pharma LLC | 1 | $19 |
| Neos Therapeutics, LP | 1 | $18 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,924 in reported general payments places this provider in the 85th percentile of 947 psychiatric/mental health providers in North Carolina.
See all psychiatric/mental health providers in North Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 45 | $5,657 |
| Modafinil | 12 | $827 |
| Gabapentin | 27 | $322 |
| Ibuprofen | 14 | $122 |
| Quetiapine Fumarate | 13 | $111 |
| Bupropion XlBupropion Hcl | 11 | $91 |
| Lamotrigine | 15 | $42 |
| Trazodone Hcl | 11 | $41 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in High Point
- Crystal MontagueHigh Point$9K
- Desiree MatthewsCharlotte$807K
- Benedetto PalomboCharlotte$671K
- Clarence RunnelsCreedmoor$339K
- Lisa SuddrethGastonia$111K
- April NandigamGreensboro$88K
- Hannah NealeyFuquay Varina$75K
- Jessica StoneRocky Mount$63K
- Deborah GranickRaleigh$28K
- Ronald PattersonFayetteville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.